Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001209191-22-057704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-17 | 2022-11-15 | RXRX | Secora Michael | CFO | F - Tax | $11.86 | -1,065 | 586.6K | -0.2% | -$12.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-15 | F | D | 1,065 | $11.86 | 586,572 | D | — | — |